Immune Checkpoint Inhibitor-related New-onset Thyroid Dysfunction: A Retrospective Analysis Using the US FDA Adverse Event Reporting System

OBJECTIVES: The study aimed to investigate the prevalence and demographic characteristics of an immune checkpoint inhibitor (ICI)-related thyroid dysfunction (ICI-TD), and to explore risk factors of poor clinical outcome using data from the US Food and Drug Administration (FDA) Adverse Event Reporti...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Difei, Yao, Jun, Yuan, Geheng, Gao, Ying, Zhang, Junqing, Guo, Xiaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895746/
https://www.ncbi.nlm.nih.gov/pubmed/35641200
http://dx.doi.org/10.1093/oncolo/oyab043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895746/
https://www.ncbi.nlm.nih.gov/pubmed/35641200
http://dx.doi.org/10.1093/oncolo/oyab043

Ejemplares similares